2023-03-19 06:24:00 ET
The main stock indexes are way down over the past year, but quite a few under-the-radar stocks have bucked the trend. All three of the stocks on this list are up near 52-week highs.
Despite an already eye-popping performance, there's a chance these stocks could climb even higher. Here's what to look out for in the months ahead from these high flyers.
Reata Pharmaceuticals (NASDAQ: RETA) was a clinical-stage biopharmaceutical company until the U.S. Food and Drug Administration (FDA) approved its first treatment on Feb. 28, 2023. The positive approval decision pushed the stock more than 100% higher overnight, and there could be more fuel in the tank.
For further details see:
3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing